IRulya Therapeutics Inc. (IRLA)
IRLA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$27.87
-13.98% on the day
Market cap
$302.2M
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | IRLA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2019 |
| SEC CIK | 0001662774 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-07-31 |
| Latest annual report | 10-K | 2026-04-10 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-10-09 |
| Latest proxy | DEFA14A | 2026-10-02 |
Source: SEC EDGAR submissions feed, 453 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +8.3% |
| 1 month | +0.4% |
| 3 months | +55.1% |
| Year to date | -95.7% |
| 1 year | -92.6% |
| From 52-week high | -96.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OCGN | Ocugen Inc. | $0.8854 | -6.52% | $300.2M |
| ARTV | Artiva Biotherapeutics Inc. | $6.29 | -7.09% | $307.5M |
| AGEN | Agenus Inc. | $6.95 | -6.46% | $313.9M |
| CABA | Cabaletta Bio Inc. | $1.69 | -5.59% | $286.5M |
| SRZN | Surrozen Inc. | $23.51 | -5.05% | $276.3M |
| CCCC | C4 Therapeutics Inc. | $2.78 | -9.15% | $342.0M |
| XFOR | X4 Pharmaceuticals Inc. | $2.60 | -7.80% | $257.8M |
| FENC | Fennec Pharmaceuticals Inc. | $10.18 | -5.04% | $356.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier